Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotinic agonist presented as a transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adult smokers.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorette Invisipatch is a nicotine replacement therapy used to support quitting tobacco by delivering steady nicotine levels.

Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms. Nicotine dependence: provides a controlled nicotine dose to facilitate gradual reduction. Relapse prevention: supports individuals who have recently stopped smoking to maintain abstinence.

Common Side Effects: - Skin irritation at the application site - Sleep disturbance or vivid dreams - Nausea or upset stomach - Headache - Dizziness - Mild sweating

Serious or Rare Side Effects: - Allergic skin reaction (rash, swelling) - Severe hypertension or tachycardia - Chest pain or arrhythmia - Seizures (rare) - Respiratory difficulty

Precautions should be taken to minimise risks associated with nicotine exposure.

Assess cardiovascular status: patients with recent myocardial infarction or uncontrolled hypertension should seek medical advice before use. Avoid use in non‑smokers: nicotine is addictive and not indicated for nicotine‑naïve individuals. Do not use while pregnant: safety has not been established; discuss with a healthcare professional. Do not use while breastfeeding: nicotine may be transferred to the infant. Do not apply to damaged or irritated skin: may increase systemic absorption. Store at room temperature: keep below 25 °C, in the original pouch, protected from moisture and direct sunlight.

Nicotine patches can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Certain antidepressants (e.g., bupropion): may raise seizure risk.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., cimetidine): may elevate nicotine plasma levels. - Alcohol: can enhance nicotine's cardiovascular effects. - Concurrent nicotine replacement products: risk of nicotine overdose.